Eiger BioPharmaceuticals ... (EIGR)
NASDAQ: EIGR
· Real-Time Price · USD
1.73
0.00 (0.29%)
At close: Apr 03, 2024, 3:59 PM
Eiger BioPharmaceuticals Revenue
Eiger BioPharmaceuticals reported an annual revenue of $15.77M, reflecting a 16.98% growth. For the quarter ending December 31, 2023, Eiger BioPharmaceuticals generated $3.8M in revenue.
Revenue (ttm)
15.77M
Revenue Growth
16.98%
Price / Sales Ratio
0.63
Revenue / Employee
281.66K
Employees
56
Market Cap
2.55M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 15.77M | +16.98% |
| Dec 31, 2022 | 13.48M | +11.05% |
| Dec 31, 2021 | 12.14M | +Infinity% |
| Dec 31, 2020 | 0 | n/a |
| Dec 31, 2019 | 0 | n/a |
| Dec 31, 2018 | 0 | n/a |
| Dec 31, 2017 | 0 | n/a |
| Dec 31, 2016 | 0 | n/a |
| Dec 31, 2015 | 0 | n/a |
| Dec 31, 2014 | 0 | n/a |
| Dec 31, 2013 | 0 | n/a |
| Dec 31, 2012 | 0 | n/a |
| Jun 30, 2011 | 0 | n/a |